Should this UGI bleed go to ICU?
Should this UGI bleed go to ICU?

Should this UGI bleed go to ICU?

Good posts start with good questions. Have an ER question? Send it here.
KEY
🔍- Deep Dive
📌- Clinical Application
🔸 - Weak Evidence
🔹 - Strong Evidence
📑 - Evidence summaries
✅ - Recommended treatment
⚠️ - Critical Information
Vitals are normal. The patient looks fine.
And yet — you still admit.
Because: “It’s a GI bleed… anything can happen.”
We’ve all said it. But let’s be honest —is that actually a good reason?
Let’s break it down.

What is Upper GI Bleed?

Upper gastrointestinal haemorrhage refers to bleeding originating proximal to the ligament of Treitz — typically from the esophagus, stomach, or duodenum.
The ligament of Treitz is the suspensory muscle of the duodenum that connects it to the diaphragm.
The most common causes include:
  • Peptic ulcer disease (PUD) — accounting for up to 67% of cases
  • Variceal bleeding — especially in patients with liver disease
  • Mallory–Weiss tears
  • Aorto-enteric fistula — rare but catastrophic, often presenting with massive, rapid bleeding

Why Do We Care?

  • One of the most common GI causes of hospitalization
  • Mortality ~ 10%
  • Hypotension (SBP <90 mmHg) → strongly associated with mortality
  • Hematemesis → worse outcomes than melena

Variceal Bleeds — A Different Beast

Even though variceal bleeds are relatively less common, they:
  • Are high-pressure systems
  • Have high rebleeding rates (up to 30%)
  • Carry significant mortality
These are high-risk from the start

The Diagnostic Challenge

Presentation is not always obvious.
  • Hematemesis (~50%) and melena (~70%) are easier to recognize
  • But patients may also present with:
    • Syncope
    • Dizziness
    • Isolated tachycardia
And to confuse things further: Brisk UGIB can present as hematochezia

The Real ED Challenge

The problem is not identifying UGIB.
The real challenge is: Risk stratification and disposition

Step 1: Is the Patient Hemodynamically Unstable?

This is the first and most important decision point.
🔹BSG guidelines recommend that patients with acute UGIB and ongoing hemodynamic instability be referred for critical care review
If the patient is unstable, the decision is already made.

If NOT unstable → Ask the next question

Could this be a variceal bleed?
If yes:
🔸Strongly consider ICU (Baveno VII recommends intensive or intermediate care)
Let’s take a few moments to discuss the “ Resuscitation Principles”
  1. Airway
Indications for prophylactic intubation (ESGE/ Baveno VII)
  • Severe haematemesis
  • Agitation
  • Inability to protect the airway.
  • Altered consciousness
  • Actively vomiting blood.
  • Patients unable to tolerate endoscopy under conscious sedation
  1. Breathing
      • Supplemental oxygen should be administered to achieve target saturations.
      • Closely observe for aspiration
  1. Circulation
    1. Volume Replacement
      1. 🔹All major guidelines agree on one thing: Restore perfusion first with crytalloid bolus (ESGE / Baveno VII / BSG)
    2. Blood Transfusion Strategy
      1. 🔹This is one of the most consistent recommendations across guidelines: Restrictive transfusion is preferred
        Target Hb: 7–9 g/dL (ESGE) / 7–8 g/dL (Baveno VII)
        • Higher targets only if:
          • Ischemic heart disease or
          • Significant comorbidities
🔍
Overtransfusion can:
  • Increase portal pressure
  • Worsen bleeding (especially variceal)
  1. Other considerations
    1. Proton Pump Inhibitors (PPI)
      1. Guidelines differ:
        🔹 ESGE → suggests high-dose IV PPI before endoscopy
        • NICE → does not recommend routine pre-endoscopy PPI
        Do not delay endoscopy for PPI infusion
    2. Antiplatelets & Anticoagulants
        • Continue aspirin (secondary prevention) - If at all interuptted start with in 3-5 days
        • Hold warfarin / DOACs initially
        • P2Y12 inhibitors → case-by-case (especially with stents → discuss with cardiology)
    3. Timing of Endoscopy
      1. 🔹 All patients → within 24 hours (ESGE)
        • Unstable → immediate after resuscitation (NICE)
    4. Adjuncts and Early Interventions
      1. Erythromycin (pre-endoscopy)
        Single dose, 250 mg given 30 – 120 minutes prior to upper gastrointestinal [GI] endoscopy
        • Consistenly recommended across guidelines
          • Improves visualization
          • Reduces repeat endoscopy and transfusion
          • Recommended in severe/ongoing bleeding
        NG Tube
        • Not routinely recommended (ESGE)
  1. Additional considerations in suspected variceal bleed (Baveno VII)
    1. These patients are automatically high-risk
      • Start early:
        • Vasoactive agents : Terlipressin / somatostatin / octreotide
        • Antibiotics : Ceftriaxone
      • Correcting Coagulation
        • FFP → Not recommended
          • It maynot correct coagulopathy and worsen volume overload worsening portal hypertension
          • Offer only if (NICE)
            • Fibrinogen level of <1 g/L
            • a prothrombin time (international normalised ratio) or activated partial thromboplastin time >1.5 times normal
        • Tranexamic acid / rFVIIa → not recommended
        • Platelets → only if actively bleeding and <50 × 10⁹/L (NICE Guidelines)
      Why?
      • Reduce portal pressure
      • Prevent infection
      • INR/PT do not reflect true coagulation status
      • It is important to focus on reducing portal hypetension over correcting INR

Step 2: Is It Truly an Upper GI Bleed?

Diagnosis is not always straightforward, but there are few clues that can help
Clues in history -
  • Known liver disease
  • Any other symptoms of liver disease like ascitis and encephalopathy
  • NSAID use (↑ risk ~4x)
  • Alcohol use
  • Prior PUD or H. pylori
  • Recent vomiting (Mallory–Weiss)
Clues in examination
  • PR exam to confirm melena
⚠️
Be cautious of imitators:
  • Iron
  • Bismuth
  • Black foods
  • True melena is jet black, tarry and foul-smelling
📌
Remeber this nuance
  • UGIB → can present as hematochezia
  • LGIB → can present as melena
Helpful Adjunct
  • BUN:Creatinine >30 → suggests UGIB

Fecal Occult Blood Test (FOBT)

  • No role in acute ED decision-making
    • American Gastroenterological Association say that the the only indication for FOBT is in colorectal cancer screening.
    • It has poor sensitivity (~25%)
      • Intermittent GI bleed or very acute GI bleed that has not had sufficient time to travel through the GI tract may not produce positive FOBT and GI bleed cannot be ruled out based on just a negative result.
    • High false positives
    • 🔍
      Many things can cause false positive
      • Foods: Animal-derived heme, high eroxidase foods (e.g. broccoli, cauliflower, cantaloupe, carrots, squash), food dye additives (red, blue, yellow)
      • Medications: Activated charcoal, Pepto-Bismol, simethicone, N-acetylcysteine
      • Iatrogenic: Topical povidone-iodine solution (often used when inserting a Foley catheter)
      • Extra-intestinal sources: Epistaxis, hemoptysis (3)
📑
A retrospective cohort study found 3 predictors of UGI bleed 1
  1. Melena
  1. BUN:Cr >30
  1. Age <50

Step 3: Risk Stratification

Common pre-endoscopy scores:
  • Glasgow Blatchford (GBS)
  • Rockall (Pre-endoscopy)
  • AIMS65
  • ABC (age, blood tests, co-morbidities) - Used to predict 30 day mortality.
Glassgow Blatchford Score
Risk Factor at Presentaion
Threshold
Score
BUN (mg/dL)
<18.2
0
18.2-22.3
+2
22.4-28
+3
28-70
+4
>70
+6
Hemoglobin (g/dL) for men
>13
0
12-13
+1
10-12
+3
<10
+6
Hemoglobin (g/dL) for women
>12
0
10-12
+1
<10
+6
Systolic blood pressure (mm Hg)
≥110
0
100–109
+1
90–99
+2
<90
+3
Pulse
≥100 (per min)
+1
Melena
Present
+1
Presentation
Syncope
+2
Co-morbidity
Liver disease history
+2
Cardiac failure present
+2
⚠️
GBS has the highest sensitivity for predicting intervention/death but no score reliably predicts rebleeding or mortality
Interpreting GBS
  1. Low Risk : GBS 0–1 → consider discharge
Supported by: NICE / BSG / ESGE / ACG
Inspite of this ESGE (2021) does mention that discharged patients should be informed of the risk of recurrent bleeding and be advised to maintain contact with the discharging hospital.
  1. Moderate Risk : GBS ≥1 → Admit under appropriate speciality for endoscopy
BSG guidelines recommend admission under gastroenterology services.
  1. High Risk : Hemodynamic instability or Suspected variceal bleed → Consider ICU
Scores support decisions , they do not replace clinical judgment. Always remeber no scoring system is foolproof. So if you have a patient with a score of 0 but they appear unwell don’t just discharge them just because of a score.

An additional marker: Lactate

📑
A retrospective cohort study showed elevated lactate = worse prognosis in GI bleed 6
  • Lactate >4 mmol/L → ~6.4× increased mortality
  • Each 1-point increase → ↑ mortality risk
notion image
🔍

What Matters

Before admitting a UGI bleed ask three simple questions:
1️⃣ Is the patient hemodynamically unstable?
👉 If yes
→ Initiate aggressive resuscitation with fluids and blood transfusion.
→ Admit to ICU ( BSG guidelines)
2️⃣ Is this truly an upper GI bleed?
Clues in history -
  • Known liver disease
  • Any other symptoms of liver disease like ascitis and encephalopathy
  • NSAID use (↑ risk ~4x)
  • Alcohol use
  • Prior PUD or H. pylori
  • Recent vomiting (Mallory–Weiss)
Clues in examination
  • PR exam to confirm melena
Helpful Adjunct
  • BUN:Creatinine >30 → suggests UGIB
👉 If yes → ask:
➡️ Could this be a variceal bleed?
👉 If yes → Admit to ICU / intermediate care (Baveno VII)
3️⃣ What is the Glasgow-Blatchford Score (GBS)?
Risk Factor at Presentaion
Threshold
Score
BUN (mg/dL)
<18.2
0
18.2-22.3
+2
22.4-28
+3
28-70
+4
>70
+6
Hemoglobin (g/dL) for men
>13
0
12-13
+1
10-12
+3
<10
+6
Hemoglobin (g/dL) for women
>12
0
10-12
+1
<10
+6
Systolic blood pressure (mm Hg)
≥110
0
100–109
+1
90–99
+2
<90
+3
Pulse
≥100 (per min)
+1
Melena
Present
+1
Presentation
Syncope
+2
Co-morbidity
Liver disease history
+2
Cardiac failure present
+2
👉 GBS 0–1 (Low Risk)→ Consider discharge with outpatient follow-up
👉 GBS >1 (Moderate Risk)→ Admit for endoscopy under gastroenterology

Want to Read More?

  1. Witting MD, Magder L, Heins AE, Mattu A, Granja CA, Baumgarten M. Emergency department predictors of upper gastrointestinal bleeding in patients without hematemesis. Am J Emerg Med 2006;24:280 –5.
  1. Gralnek IM, Stanley AJ, Morris AJ, et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021. Endoscopy 2021; 53:300–32.
  1. de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol 2022; 76:959–74.
  1. Siau, Keith, et al. "British Society of Gastroenterology (BSG)-led multisociety consensus care bundle for the early clinical management of acute upper gastrointestinal bleeding." Frontline Gastroenterology 11.4 (2020): 311-323.
  1. National Institute for Health and Care Excellence (NICE). Acute upper gastrointestinal bleeding in over 16s: management (CG141). London: NICE; 2012. Updated August 2016.
  1. Shah, Amish, et al. "Prognostic use of lactate to predict inpatient mortality in acute gastrointestinal hemorrhage." The American journal of emergency medicine 32.7 (2014): 752-755.
📚Want to keep learning?

Stay Updated
📸Follow on Instagram
Quick tips, new posts, and simple clinical pearls.

What they asked…

This is an ongoing project that attempts to address questions that have appeared in past examination papers.
Feel free to browse 😊

Disclaimer : For educational use only — always follow your clinical judgment and local protocols.